Apolipoprotein B: can we continue to ignore?

Curr Opin Lipidol. 2010 Feb;21(1):99-100. doi: 10.1097/MOL.0b013e32833538a4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Apolipoproteins B / metabolism*
  • Atherosclerosis / metabolism
  • Biomarkers / metabolism
  • Cholesterol, LDL / metabolism
  • Clinical Trials as Topic
  • Humans
  • Risk Assessment

Substances

  • Apolipoproteins B
  • Biomarkers
  • Cholesterol, LDL